1. Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Pearce LR, Huang X, Boudeau J, Pawłowski R, Wullschleger S, Deak M, Ibrahim AF, Gourlay R, Magnuson MA, Alessi DR (2007) Biochem J 405(3): 513-22
    › Primary publication · 17461779 (PubMed) · PMC2267312 (PubMed Central)
  2. Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations. Pino MF, Kim KA, Shelton KD, Lindner J, Odili S, Li C, Collins HW, Shiota M, Matschinsky FM, Magnuson MA (2007) J Biol Chem 282(18): 13906-16
    › Primary publication · 17353190 (PubMed)
  3. Early pancreatic development requires the vertebrate Suppressor of Hairless (RBPJ) in the PTF1 bHLH complex. Masui T, Long Q, Beres TM, Magnuson MA, MacDonald RJ (2007) Genes Dev 21(20): 2629-43
    › Primary publication · 17938243 (PubMed) · PMC2000326 (PubMed Central)
  4. Directed differentiation of embryonic stem cells into bladder tissue. Oottamasathien S, Wang Y, Williams K, Franco OE, Wills ML, Thomas JC, Saba K, Sharif-Afshar AR, Makari JH, Bhowmick NA, DeMarco RT, Hipkens S, Magnuson M, Brock JW, Hayward SW, Pope JC, Matusik RJ (2007) Dev Biol 304(2): 556-66
    › Primary publication · 17289017 (PubMed) · PMC1994155 (PubMed Central)
  5. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Burgess SC, He T, Yan Z, Lindner J, Sherry AD, Malloy CR, Browning JD, Magnuson MA (2007) Cell Metab 5(4): 313-20
    › Primary publication · 17403375 (PubMed) · PMC2680089 (PubMed Central)
  6. Caveats and considerations for performing pancreas-specific gene manipulations in the mouse. Magnuson MA, Burlison JS (2007) Diabetes Obes Metab : 5-13
    › Primary publication · 17919173 (PubMed)
  7. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, Doliba N, Han Y, Taub R, Grimsby J (2006) Diabetes 55(1): 1-12
    › Primary publication · 16380470 (PubMed)
  8. Targeted deletion of a cis-regulatory region reveals differential gene dosage requirements for Pdx1 in foregut organ differentiation and pancreas formation. Fujitani Y, Fujitani S, Boyer DF, Gannon M, Kawaguchi Y, Ray M, Shiota M, Stein RW, Magnuson MA, Wright CV (2006) Genes Dev 20(2): 253-66
    › Primary publication · 16418487 (PubMed) · PMC1356115 (PubMed Central)
  9. Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes. Stiles BL, Kuralwalla-Martinez C, Guo W, Gregorian C, Wang Y, Tian J, Magnuson MA, Wu H (2006) Mol Cell Biol 26(7): 2772-81
    › Primary publication · 16537919 (PubMed) · PMC1430339 (PubMed Central)
  10. RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. Lee JY, Ristow M, Lin X, White MF, Magnuson MA, Hennighausen L (2006) J Biol Chem 281(5): 2649-53
    › Primary publication · 16326700 (PubMed)